PharmaVoice

DECEMBER 4, 2023

Market expectations for obesity drugs are soaring and competition is heating up. But hitting the heights will require overcoming payer and other issues.

246

246

STAT

DECEMBER 8, 2023

The Food and Drug Administration on Friday approved the world’s first medicine based on CRISPR gene-editing technology, a groundbreaking treatment for sickle cell disease that delivers a potential cure for people born with the chronic and life-shortening blood disorder. The new medicine , called Casgevy, is made by Vertex Pharmaceuticals and CRISPR Therapeutics.

Drug Development 364

Drug Development 364

BioPharma Dive

DECEMBER 8, 2023

In addition to clearing Vertex Pharmaceuticals and CRISPR Therapeutics’ Casgevy, the FDA also granted an early OK to Bluebird bio’s sickle cell treatment Lyfgenia.

138

138

The Pharmacist

DECEMBER 7, 2023

The Department of Health and Social Care (DHSC) has today launched its consultation into pharmacy supervision. It proposes to: enable pharmacists to authorise pharmacy technicians to carry out, or supervise others carrying out, the preparation, assembly, dispensing, sale and supply of medicines enable pharmacists to authorise any member of the pharmacy team to hand out […] The post Breaking: Pharmacy supervision consultation launches appeared first on The Pharmacist.

Pharmacy Technician 125

Pharmacy Technician 125

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

PharmaVoice

DECEMBER 4, 2023

AstraZeneca’s Gemma Satterthwaite talks to the company’s ambition to transform the entire care experience for patients with blood cancers.

246

246

STAT

DECEMBER 7, 2023

TIJUANA, Mexico — Just over a decade ago, when Crystal Pérez Lira needed an abortion, she had to leave Mexico. The procedure was illegal in her home state of Baja California and so deeply stigmatized that even Pérez Lira supported the procedure only for those who were raped. Until she unexpectedly got pregnant. She traveled to the U.S. for help, walking alone across the border from Tijuana to San Diego, first for a health check and a compulsory ultrasound, and then back for a se

362

362

The Pharmacist

DECEMBER 8, 2023

NHS England is not confident IT solutions will be in place for the planned 31 January rollout of Pharmacy First, senior officials have revealed. The Government had already said the rollout date was subject to the ‘appropriate digital systems being in place’ to support the services. However, during a public meeting yesterday NHS England’s board was told […] The post NHS England board questions if IT will be in place for January Pharmacy First rollout appeared first on The Pharmacist.

112

112

PharmaVoice

DECEMBER 6, 2023

This year’s many firsts included a vaccine for RSV and a drug that slows Alzheimer’s disease.

Vaccines 265

Vaccines 265

STAT

DECEMBER 6, 2023

As a teenager, Marie Tornyenu was always having to explain herself. If it wasn’t the chronic absences that had her doing homework from a hospital bed, it was the quilted blanket she carried with her on the days she could attend class. “It was a running joke that I was like 80 years old,” she said. “I would usually just laugh it off because the alternative was too depressing.

Hospitals 361

Hospitals 361

BioPharma Dive

DECEMBER 7, 2023

The funding is indicative of investor interest in an area of drug research that involves at least a dozen startups and multiple publicly traded companies.

129

129

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

The Pharmacist

DECEMBER 6, 2023

A general practice on the south coast is using a giant advent calendar in its high-street windows to help patients stay well during the winter. Pharmacist partner in the Brighton Health and Wellbeing Centre Shilpa Patel told The Pharmacist that the self-care display is intended to educate patients, tackle misinformation, and relieve winter pressures on […] The post GP practice launches ‘self-care’ advent calendar to help relieve winter pressures appeared first on The Pharmacist.

118

118

PharmExec

DECEMBER 5, 2023

TAR-200 has a novel targeted releasing system for the treatment of patients with Bacillus Calmette-Guérin-unresponsive high-risk non-muscle-invasive bladder cancer who are ineligible for bladder removal surgery.

116

116

STAT

DECEMBER 4, 2023

The Senate health care committee will consider a sweeping bill next week meant to combat the opioid epidemic, according to four lobbyists and a congressional aide familiar with the legislation.  The proposal would reauthorize a number of programs first created by the SUPPORT Act, an addiction-focused bill that Congress first passed in 2018. Many of those programs’ authorizations expired earlier this year, however, leading addiction treatment advocates to fret that lawmakers —

359

359

Pharma Times

DECEMBER 8, 2023

One-third of patients who received Pfizer’s COVID-19 vaccine had unintended immune responses - News - PharmaTimes

Immunity 132

Immunity Immunization Vaccines 132

The Pharmacist

DECEMBER 4, 2023

NHS England (NHSE) has released optional guidance on shared workforce models for pharmacists, although the Company Chemists’ Association (CCA) has warned that complexity could hinder their uptake. The guidance, published last week, sets out optional workforce models that community pharmacies and hospital pharmacy departments may wish to consider in collaboration with primary care networks (PCNs). […] The post Doubts raised over NHSE shared workforce guidance for pharmacists appeared first

Community Pharmacies 119

Community Pharmacies Hospitals 119

PharmExec

DECEMBER 6, 2023

Experts from Hootsuite noted that the primary social media ROI concern for healthcare companies is the time and money it takes to maintain a multi-platform presence.

119

119

STAT

DECEMBER 6, 2023

The New England Journal of Medicine, the world’s oldest continually published medical journal, publicly reckoned with its history and complicity surrounding slavery and racism Wednesday, publishing the first of a series of essays by independent historians on the role the prestigious publication has played in perpetuating racist thinking in medicine that continues to this day.

357

357

pharmaphorum

DECEMBER 7, 2023

AbbVie has announced its second major takeover deal in the space of a few days, offering $8.7 billion to buy central nervous system drug specialist Cerevel Therapeutics which spun out of Pfizer in 2018.

112

112

The Pharmacist

DECEMBER 4, 2023

Nearly three-quarters of respondents to a survey by the Association of Independent Multiple Pharmacies (AIMp) expressed the view that Community Pharmacy England (CPE) is not currently representative of community pharmacies in England. Among almost 380 responses, 73.8% opted for ‘no’ in answer to the question of, ‘Do you think CPE is currently representative of community […] The post AIMp survey suggests dissatisfaction with CPE representation appeared first on The Pharmacist.

Community Pharmacies 115

Community Pharmacies 115

PharmExec

DECEMBER 8, 2023

FDA approval of bluebird bio’s Lyfgenia and Vertex Pharmaceuticals' and CRISPR Therapeutics’ Casgevy marks significant milestone in the treatment of sickle cell disease.

115

115

STAT

DECEMBER 4, 2023

OK, marijuana is now legal. So where’s the public health approach? Strictly speaking, marijuana use isn’t fully legal across the U.S. yet. But when Montana and Missouri have legalized recreational use and the Senate is debating legal banking for cannabis companies, you know it’s all over but the shouting.

358

358

World Pharma News

DECEMBER 8, 2023

Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older. Additionally, one of these therapies, Casgevy, is the first FDA-approved treatment to utilize a type of novel genome editing technology, signaling an innovative advancement in the field of gene therapy.

110

110

The Pharmacist

DECEMBER 6, 2023

We speak to the Pharmacist/Pharmacy Team of the Year Award shortlisted pharmacists ahead of this year’s General Practice Awards, to be held on 8 December in London. The fourth entry under the spotlight from this year’s shortlist of six is the Haringey GP Federation clinical pharmacy team. Among the significant work of the Haringey team […] The post Meet the Pharmacy Team of the Year Award shortlist: Haringey GP Federation clinical pharmacy team appeared first on The Pharmacist.

102

102

Pharmaceutical Technology

DECEMBER 6, 2023

Seattle Children's launched BrainChild Bio to focus on expediting the development of CAR T-cell therapies in central nervous system tumours.

Hospitals 124

Hospitals 124

STAT

DECEMBER 5, 2023

WASHINGTON — Pfizer has decided to leave the Biotechnology Innovation Organization, according to two sources familiar with the decision. The departure is a blow to BIO, which represents members ranging from small biotech startups to massive pharmaceutical companies. The group on Tuesday announced its new CEO, rare disease advocate and biotech executive John Crowley.

Pharmaceutical Companies 356

Pharmaceutical Companies Pharmaceutical Companies 356

BioPharma Dive

DECEMBER 8, 2023

Casgevy, the first CRISPR therapy approved by the FDA, will cost $2.2 million, while a competing genetic medicine also cleared Friday is priced at $3.1 million.

117

117

The Pharmacist

DECEMBER 7, 2023

The number of students accepted onto undergraduate pharmacy programmes across the UK has increased 3% in a year, according to latest data from the Universities and Colleges Admissions Service (UCAS). Community Pharmacy England (CPE) welcomed the rise and hoped the news ‘bodes well’ for recent commitments made by NHS England to expanding pharmacy training.

Community Pharmacies 106

Community Pharmacies 106

Pharma Times

DECEMBER 6, 2023

The neurological condition currently affects one in 300 people in the UK - News - PharmaTimes

145

145

STAT

DECEMBER 5, 2023

Here are two things that are true. The world needs more effective flu vaccines. And pharmaceutical companies that learned of the vaccine-making power of the messenger RNA platform during the Covid-19 pandemic need new markets for their technology.

Vaccines 355

Vaccines Pharmaceutical Companies Pharmaceutical Companies 355

The Guardian - Pharmaceutical Industry

DECEMBER 2, 2023

Links between the deaths of UK patients and the popular drug have spurred on action among expats in Jávea and beyond As Britain faced widespread frosts last week, there were blue skies, a warm breeze and temperatures above 20C on white sand beaches dotted with palm trees in Jávea on the Costa Blanca. About 5,000 Britons live in this small town, once walled and fortified to protect it from marauding pirates.

111

111

The Pharmacist

DECEMBER 8, 2023

A new study involving nearly 9,000 children deficient in Vitamin D found that supplementing children’s diets with Vitamin D had very little impact on the strength of a child’s bones or the number of fractures they had. The findings, which the researchers describe as ‘striking’, are published in the Lancet Diabetes & Endocrinology and will likely have […] The post Vitamin D supplements do not prevent bone fractures in children, suggests study appeared first on The Pharmacist.

Diabetes 102

Diabetes 102

pharmaphorum

DECEMBER 4, 2023

Roche has agreed a deal to acquire US biotech Carmot Therapeutics that if consummated will thrust it into the increasingly competitive market for incretin-based therapies for diabetes and obesity. The Swiss pharma group has agreed to pay $2.7 billion upfront in cash when the deal closes, with shareholders in the US company also in line for up to $400 million if the drug programmes covered by the agreement meet various milestones.

Diabetes 110

Diabetes 110

STAT

DECEMBER 5, 2023

CVS Health is promising to simplify how its pharmacies get paid for drugs. But that doesn’t mean the drugs will get cheaper. The country’s biggest pharmacy chain said it’s switching to a system where pharmacy benefit managers, employers, and other insurers pay for drugs based on the cost of the drug plus a set markup and dispensing fee.

Drug Pricing 354

Drug Pricing 354

BioPharma Dive

DECEMBER 8, 2023

The setbacks for Merck demonstrate the challenge drug developers face in improving on Keytruda, which has brought in at least $18 billion so far this year for its maker.

Drug Development 111

Drug Development 111

The Pharmacist

DECEMBER 6, 2023

NHS England is to review its commissioning recommendations for cardiovascular disease (CVD) after a cheaper direct oral anticoagulant (DOAC) has appeared on the market, Pulse PCN understands. Under the 2022/23 Network DES, NHS England had incentivised PCNs to start prescribing edoxaban to new patients and consider switching patients over, following a procurement deal with the […] The post NHS drug deal to be reviewed after cheaper DOAC released appeared first on The Pharmacist.

106

106